NCT02352350

Brief Summary

Blood lactate levels will be measured using a simple handheld device at time of return of spontaneous circulation (ROSC) following out of hospital cardiac arrest (OHCA). Patient outcomes tracked will include rate of survival to hospital discharge, rate of 6 month survival, and neurological status. The hypothesis for this pre-hospital study is to confirm the previous in-hospital findings that very high blood lactate after ROSC is associated with very high mortality and severe neurological impairment.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2017

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 2, 2015

Completed
2.6 years until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

October 24, 2017

Status Verified

October 1, 2017

Enrollment Period

1.2 years

First QC Date

December 4, 2014

Last Update Submit

October 20, 2017

Conditions

Keywords

Pre-Hospital Cardiac ArrestBlood Lactate LevelNeurological Injury

Outcome Measures

Primary Outcomes (2)

  • Blood Lactate Levels correlated with survival

    Changes in hour 0, approximately hour 12, approximately day 14, and 6 months

  • Blood Lactate Levels correlated with Neurological Outcomes

    Overall Neurologic function will be assessed using available clinical information and Cerebral Performance Categories, a composite measure including available neurologic and clinical assessments CPC 1. Good cerebral performance: conscious, alert, able to work, might have mild neurologic or psychological deficit. CPC 2. Moderate cerebral disability: conscious, sufficient cerebral function for independent activities of daily life. Able to work in sheltered environment. CPC 3. Severe cerebral disability: conscious, dependent on others for daily support because of impaired brain function. Ranges from ambulatory state to severe dementia or paralysis. CPC 4. Coma or vegetative state: any degree of coma without the presence of all brain death criteria. Unawareness, even if appears awake (vegetative state) without interaction with environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness. CPC 5. Brain death: apnea, areflexia, EEG silence, etc.

    Changes in week 2 and 6 months

Study Arms (1)

Cardiac Arrest Patients

All adult patients with non traumatic cardiac arrest in Alachua County Florida will have blood lactate levels taken and neurological outcomes performed based on the Cerebral Performance Categories (CPC) Scale

Other: Blood Lactate LevelsOther: Neurological Outcomes

Interventions

Blood lactate levels will be performed on all participants.

Cardiac Arrest Patients

Neurological outcomes will be performed on all participants based on the Cerebral Performance Categories (CPC) Scale.

Also known as: Cerebral Performance Categories (CPC) Scale
Cardiac Arrest Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All primary cardiac arrest patients in Alachua County with prehospital return of spontaneous circulation (ROSC) in Alachua County, FL.

You may qualify if:

  • All adult patients (≥ 18 years of age)
  • Non-traumatic primary cardiac arrest

You may not qualify if:

  • Patients with advanced directives precluding resuscitation,
  • Traumatic cardiac arrest, and
  • Irreversible signs of death (rigor mortis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart ArrestTrauma, Nervous System

Interventions

cytidylyl-(3'-5')-cytidineWeights and Measures

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesNervous System DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Karl Huesgen, MD

    University of Florida

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2014

First Posted

February 2, 2015

Study Start

September 1, 2017

Primary Completion

November 1, 2018

Study Completion

January 1, 2019

Last Updated

October 24, 2017

Record last verified: 2017-10